AVEO Pharmaceuticals, Inc. (AVEO) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
09M18M26M35M44M52M61M70MQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Operating Expenses

Research And Development Expenses
02M5M8M10M12M15M18M20MQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

EBITDA

EBITDA
-20M-17M-15M-12M-10M-7M-5M-2M1Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022

EPS

Revenue Variation (%)

Revenue Variation
-818447096122148174200Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
0255075100125150175200Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Revenue YoY Variation (%)

Revenue YoY Variation
02505007501K1K2K2K2KQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
02505007501K1K2K2K2KQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Price-to-Earning Ratio

P/E Ratio
-20-17-15-12-10-7-4-21Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Income Breakdown

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
000111222Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Expense Ratios

Research And Ddevelopement To Revenue
000001111Q3 2021Q4 2021Q1 2022Q2 2022Q3 2022
💰 Cash Flow Statement

Operating Cash Flow

Operating Cash FlowFree Cash Flow
062K125K188K250K312K375K438K500KQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Free Cash Flow

Cash At End Of Period
011M22M34M45M56M68M79M90MQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
0875K2M3M4M4M5M6M7MQ3 2021Q4 2021Q1 2022Q2 2022Q3 2022
🏦 Balance Sheet
📈 Key Metrics